Market Research Logo

Global Diabetes Market: Industry Analysis & Outlook (2016-2020)

Global Diabetes Market: Industry Analysis & Outlook (2016-2020)

Diabetes, often referred to as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body’s cells do not respond properly to insulin, or both. Diabetes is a disorder of metabolism, the process by which the body uses digested food for energy. There are two main forms of the diabetes. People with type 1 diabetes typically make none of their own insulin and therefore require insulin injections to survive. People with type 2 diabetes, the form that comprises some 90% of cases, usually produce their own insulin, but not enough or they are unable to use it properly. People with type 2 diabetes are typically overweight and sedentary, two conditions that raise a person’s insulin needs. It may also be seen during pregnancy.

The report “Global Diabetes Market” provides an in-depth analysis of the global diabetes market, along with the regional markets. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry, Novo-Nordisk, Sanofi-Aventis, Eli Lilly and Takeda are being profiled.

The key factors driving the growth of diabetes market are growing ageing population, growing urbanization, increasing healthcare expenditure, accelerating economic growth, growing obese population, opportunities for growth in emerging markets and bariatric surgery for treating diabetes on the rise. Some of the noteworthy trends and developments of this industry are advances in medical devices, rising prevalence of diabetes and desk bound lifestyle and second hand smoke. However, the expansion of the market is hindered by increasing diabetes cost.


1. Diabetes Market Overview
1.1 An Introduction
1.2 Types of Diabetes
Table 1: Types of diabetes
1.3 Diabetes Risk Factors
1.4 How is Diabetes Diagnosed and Managed?
1.5 Treatment of Diabetes
2. Global Diabetes Market
2.1 Global Diabetes Population
Table 2: Global Diabetes Population (2007-2015)
2.2 Global Diabetes Forecasted Population
Table 3: Global Diabetes Forecasted Population (2016-2020)
2.3 Global Diabetes Population by Region
Table 4: Global Diabetes Population by Region (2015)
2.4 Global Diabetes Population by Areas
Table 5: Global Diabetes Population by Areas (2015)
2.5 Global Diabetes Population by Gender
Table 6: Global Diabetes Population by Gender (2015)
2.6 Global Diabetes Population by Age Distribution
Table 7: Global Diabetes Population by Age Distribution (2015)
2.7 Global Diabetes Statistics
Table A: Global Diabetes Statistics (2015)
2.8 Global Undiagnosed Diabetic Population by Region
Table B: Proportion and Number of People (20-79 Years) Living With Diabetes Who Are Undiagnosed By Region (2015)
2.9 Top Ten Countries for No. of Children with Type 1 Diabetes
Table 8: Top Ten Countries for Number of Children with Type 1 Diabetes 0-14 Years (2015)
2.10 Top Ten Countries/Territories for No. of People with Diabetes
Table 9: Top Ten Countries/Territories for Number of People with Diabetes 20-79 Years (2015)
3. Diabetes Treatment Market
3.1 Global Diabetes Care Market by Treatment Class
Table 10: Global Diabetes Care Market by Treatment Class (August 2016)
3.1 Global Diabetes Care Market by Treatment Class
Table 11: Global Insulin Market Forecast by Value (2016-2020)
Table 12: Global OAD Market Forecast by Value (2016-2020)
Table 13: Global GLP-1 Market Forecast by Value (2016-2020)
3.2 Global Insulin Market by Segments
Table 14: Global Insulin Market by Segments (August 2016)
3.3 Global Insulin Market by Region
Table 15: Global Insulin Market by Region (August 2016)
3.4 Global Insulin Users by Region
Table C: Global Insulin Users by Region (2015)
3.5 Global Injectable Diabetes Drugs Sales by Value
Table 16: Global Injectable Diabetes Drugs Sales by Value (2011-2015)
3.6 Global Injectable Diabetes Drugs Sales Forecast by Value
Table 17: Global Injectable Diabetes Drugs Sales Forecast by Value (2016-2020)
4. Regional Market Analysis
4.1 Western Pacific
4.1.1 Western Pacific - Diabetes Statistics
Table D: Western Pacific - Diabetes Statistics (2015)
4.1.2 China - Diabetes Statistics
Table E: China - Diabetes Statistics (2015)
Table 18: Chinese Diabetes Care Market by Treatment Class (August 2016)
Table 19: Chinese Insulin Market by Segments (August 2016)
4.1.3 Japan - Diabetes Statistics
Table F: Japan - Diabetes Statistics (2015)
Table 20: Japanese Insulin Market by Segments (August 2016)
4.1.4 Other Countries - Diabetes Statistics
Table G: Diabetes in Other Major Countries of Western Pacific (2015)
4.2 South-East Asia
4.2.1 South-East Asia- Diabetes Statistics
Table H: South-East Asia- Diabetes Statistics (2015)
4.2.2 India - Diabetes Statistics
Table I: India - Diabetes Statistics (2015)
4.2.3 Other Countries - Diabetes Statistics
Table J: Diabetes in Other Countries of South East Asia (2015)
4.3 Europe
4.3.1 Europe - Diabetes Statistics
Table K: Europe - Diabetes Statistics (2015)
Table 21: Europe Diabetes Care Market by Treatment Class (August 2016)
Table 22: European Insulin Market by Segments (August 2016)
4.3.2 Germany- Diabetes Statistics
Table L: Germany- - Diabetes Statistics (2015)
4.3.3 Other Countries - Diabetes Statistics
Table M: Diabetes in Other Countries of Europe (2015)
4.4 North America and Caribbean
4.4.1 North America and Caribbean- Diabetes Statistics
Table N: North America and Caribbean- Diabetes Statistics (2015)
4.4.2 The US - Diabetes Statistics
Table O: The US - Diabetes Statistics (2015)
Table 23: The US Diabetes Care Market by Treatment Class (August 2016)
Table 24: The US Insulin Market by Segments (August 2016)
4.4.3 Other Countries - Diabetes Statistics
Table P: Diabetes in Other Countries of the North American and Caribbean Region (2015)
4.5 Middle East and North Africa
4.5.1 Middle East and North Africa- Diabetes Statistics
Table Q: Middle East and North Africa- Diabetes Statistics (2015)
4.5.2 Other Countries - Diabetes Statistics
Table R: Diabetes in Other Countries of the Middle East and North Africa Region (2015)
4.6 South and Central America
4.6.1 South and Central America- Diabetes Statistics
Table S: South and Central America- Diabetes Statistics (2015)
4.6.2 Other Countries - Diabetes Statistics
Table T: Diabetes in Other Countries of the South and Central America Region (2015)
4.7 Africa
4.7.1 Africa - Diabetes Statistics
Table U: Africa - Diabetes Statistics (2015)
4.7.2 Other Countries - Diabetes Statistics
Table V: Other Countries - Diabetes Statistics (2015)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Growing Ageing Population
Table 25: Global Ageing Population (2006-2015)
5.1.2 Growing Urbanization
Table 26: Global Urban Population (2007-2015)
5.1.3 Increasing Healthcare Expenditure
Table 27: Global Healthcare Expenditure (2007-2015)
5.1.4 Accelerating Economic Growth
Table 28: Global GDP Growth (2007-2015)
5.1.5 Growing Obese Population
Table 29: Global Obese Population (2006-2015)
5.1.6 Opportunities for Growth in Emerging Markets
5.1.7 Bariatric Surgery for Treating Diabetes on the Rise
5.2 Market Trends
5.2.1 Advances in Medical Devices
5.2.2 Rising Prevalence of Diabetes
5.2.3 Desk Bound Lifestyle and Second hand Smoke
5.3 Challenges
5.3.1 Increasing Diabetes Cost
6. Competitive Landscape
6.1 Top Ten Diabetes Drug by Company
Table W: Top Ten Diabetes Drug by Company (2015)
6.2 Global Diabetes Care Market Share by Company
Table 30: Global Diabetes Care Market Share by Company (August 2016)
6.3 Global Modern Insulin Market Share by Company
Table 31: Global Modern Insulin Market Share by Company (August 2016)
6.4 The US Modern Insulin Market Shares by Company
Table 32: The US Modern Insulin Market Shares by Company (August 2016)
6.5 Europe Modern Insulin Market Shares by Company
Table 33: Europe Modern Insulin Market Shares by Company (August 2016)
6.6 Chinese Insulin Market Shares by Company
Table 34: Chinese Insulin Market Shares by Company (August 2016)
6.7 Japanese Modern Insulin Market Shares by Company
Table 35: Japanese Modern Insulin Market Shares by Company (August 2016)
7. Company Profiles
7.1 Sanofi
7.1.1 Business Overview
Table 36: Sanofi’s Net Sales Share by Business Segment (2015)
Table 37: Sanofi’s Net Sales Share by Region (2015)
7.1.2 Financial Overview
Table 38: Sanofi’s Net Sales and Net Income (2011-2015)
7.1.3 Business Strategies
7.2 Takeda
7.2.1 Business Overview
Table 39: Takeda’s Revenue Share by Business Segments (2016)
Table 40: Takeda’s Revenue Share by Region (2016)
7.2.2 Financial Overview
Table 41: Takeda’s Revenues and Net Income (2012-2016)
7.2.3 Business Strategies
7.3 Eli Lilly
7.3.1 Business Overview
Table 42: Eli Lilly’s Revenue Share by Business Segments (2015)
Table 43: Eli Lilly’s Revenue Share by Region (2015)
7.3.2 Financial Overview
Table 44: Eli Lilly’s Revenues and Net Income (2011-2015)
7.3.3 Business Strategies
7.4 Novo Nordisk
7.4.1 Business Overview
Table 45: Novo Nordisk’s Net Sales Share by Business Segments (2015)
Table 46: Novo Nordisk’s Net Sales Share by Region (2015)
7.4.2 Financial Overview
Table 47: Novo Nordisk’s Net Sales and Net Profit (2011-2015)
7.4.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report